Beta-blocker Discontinuation in Heart Failure With Preserved Ejection Fraction
NCT05174351 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 30
Last updated 2025-09-29
Summary
This is a prospective pilot study to evaluate changes before and 4 weeks after beta-blocker withdrawal in 30 HFpEF patients.
Conditions
Interventions
- OTHER
-
beta blocker discontinuation
beta blocker discontinuation
Sponsors & Collaborators
-
UConn Health
lead OTHER
Principal Investigators
-
Kai Chen, MD,PhD · UConn Health
Study Design
- Allocation
- NA
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 50 Years
- Max Age
- 80 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2021-12-20
- Primary Completion
- 2027-11-01
- Completion
- 2027-11-01
Countries
- United States
Study Locations
More Related Trials
-
Impact of Beta-blockers on Physical Function in HFpEF
NCT04767061 ·Status: COMPLETED ·Phase: PHASE4
-
An Observational Study of the Functional Capacity of Heart Failure
NCT02350114 ·Status: COMPLETED ·Phase: NA
-
The Use of Advanced Imaging in HFpEF
NCT06905405 ·Status: RECRUITING
-
Monitoring Community Trends in Heart Failure
NCT00035724 ·Status: COMPLETED
-
Interval Training in Heart Failure
NCT03955029 ·Status: RECRUITING ·Phase: NA
-
Beta-Blocker Continuation Versus Interruption in Heart Failure Worsening
NCT00162565 ·Status: COMPLETED ·Phase: PHASE4
-
Tele-HF: Yale Heart Failure Telemonitoring Study
NCT00303212 ·Status: COMPLETED ·Phase: NA
-
Beta-Blockers in Heart Failure: Pharmacy-level Intervention Comparison
NCT01002456 ·Status: COMPLETED ·Phase: NA
-
Understanding and Treating Heart Failure With Preserved Ejection Fraction: Novel Mechanisms, Diagnostics and Potential Therapeutics
NCT02052804 ·Status: COMPLETED
-
Cardiopulmonary Interactions in Patients With Heart Failure
NCT03317314 ·Status: WITHDRAWN
-
Value of Intense Phenotyping in Heart Failure With Preserved Ejection Fraction
NCT05479669 ·Status: RECRUITING
-
Contemporary Modalities in Treatment of Heart Failure
NCT02536443 ·Status: UNKNOWN
-
Comprehensive Medication Monitoring on Heart Failure Patient Outcomes
NCT03519477 ·Status: WITHDRAWN ·Phase: NA
-
Serial Measurements of Biomarker in Patients With Acute Decompensated Heart Failure
NCT00514384 ·Status: COMPLETED
-
Day-care Unit for Patients With Refractory Heart Failure
NCT03056651 ·Status: UNKNOWN ·Phase: NA
-
IMPROVE HF: Registry to Improve the Use of Evidence-Based Heart Failure Therapies in the Outpatient Setting
NCT00303979 ·Status: COMPLETED
-
A Study of Patients Hospitalized With Acute Heart Failure With Reduced Ejection Fraction (HFrEF)
NCT03515655 ·Status: UNKNOWN
-
Evaluation of NT PRO BNP Guided Therapy on Hospitalization Rate and Mortality in Patients With Chronic HF NYHA II-IY
NCT00469001 ·Status: COMPLETED
-
A Pilot Feasibility Study in Recovered Heart Failure
NCT02859311 ·Status: UNKNOWN ·Phase: PHASE4
-
Improving Care of Patients With Heart Failure
NCT01461681 ·Status: COMPLETED ·Phase: NA
-
Heart Failure and Therapeutic Education
NCT07006350 ·Status: COMPLETED
-
Study of the Prognosis of Patients With Heart Failure With Preserved Ejection Fraction
NCT05496439 ·Status: COMPLETED
-
Accelerated Pacing and Cardiac Filling Pressures During Exercise in Patients With Heart Failure With Preserved Ejection Fraction
NCT07270536 ·Status: RECRUITING ·Phase: NA
-
Impact of Hear Failure on Lungs in Patients With Heart Failure
NCT05191459 ·Status: COMPLETED
-
Evaluation of Clinical and Genetic Modifiers of Long-term Survival in Heart Failure
NCT03461107 ·Status: UNKNOWN